Zinc finger protein 649 (ZNF649) is a transcription factor that belongs to the broad family of C2H2-type zinc finger proteins, which are known for their roles in DNA binding and the regulation of gene expression. ZNF649, like other zinc finger proteins, is thought to interact with specific DNA sequences to regulate the transcription of target genes. The precise biological functions and regulatory mechanisms of ZNF649 are still under investigation, but it is suggested that it plays a role in cellular processes including proliferation and differentiation. Understanding how the expression of ZNF649 can be modulated is of interest in the field of molecular biology, as it could provide insights into the functioning and regulation of genes involved in complex cellular pathways.
To explore the possibility of modulating the expression of ZNF649, researchers have considered the use of various chemical compounds known to alter gene expression at the transcriptional level. Compounds such as 5-Azacytidine and Decitabine are known inhibitors of DNA methyltransferases and could decrease the expression of ZNF649 by altering methylation patterns at the gene's promoter region, thereby affecting the binding affinity of transcription factors. Similarly, histone deacetylase (HDAC) inhibitors like Trichostatin A, Vorinostat, and Sodium Butyrate could also potentially repress ZNF649 expression. These inhibitors work by inducing a more open chromatin structure, enhancing histone acetylation, and consequently, reducing the transcriptional repression of various genes. While these compounds provide a framework for downregulating ZNF649, any specific interaction with ZNF649 would require targeted studies to validate these effects. Understanding these interactions could contribute significantly to our knowledge of gene regulation mechanisms, highlighting the intricate balance of transcriptional control within cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound may disrupt DNA methylation patterns upon integration, leading to the downregulation of ZNF649 by altering transcription factor binding sites. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A could reduce ZNF649 expression by inhibiting histone deacetylases, which results in a more open chromatin state and decreased gene transcription. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate might decrease the transcription of ZNF649 by inhibiting histone deacetylases, leading to alterations in histone acetylation and less transcriptional repression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid may decrease ZNF649 transcription by targeting histone deacetylases, promoting histone acetylation, and thereby facilitating transcriptional activation of other genes while repressing ZNF649. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
This HDAC inhibitor could specifically repress ZNF649 expression by altering the acetylation status of histones associated with the ZNF649 gene promoter. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine might reduce ZNF649 expression by inducing hypomethylation of DNA at the gene locus, which typically represses gene activity through changes in DNA-protein interactions. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin has the potential to decrease ZNF649 expression through robust inhibition of histone deacetylases, leading to increased acetylation and disruption of transcriptional repressors. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
By inhibiting multiple HDACs, Panobinostat might cause a broad reduction in ZNF649 expression due to enhanced acetylation and disruption of negative transcriptional controls. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Mocetinostat might lead to the targeted repression of ZNF649 expression through the inhibition of class I HDACs, thereby modifying histone acetylation at the gene site. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid could inhibit ZNF649 expression by reducing histone deacetylase activity, which results in an open chromatin configuration and decreased binding of transcriptional repressors to the gene promoter. | ||||||